title: MIR in atypical idiopathic inflammatory demyelinating disease treated with methylprednisolone and cyclophosphamide.
authors.affiliation: Department of Neurology, Kamillus-Klinik, Asbach, Germany.
authors.forename: U
authors.initials: U
authors.lastname: Kallweit
authors.forename: D
authors.initials: D
authors.lastname: Pöhlau
authors.forename: D
authors.initials: D
authors.lastname: Pauleit
authors.forename: M
authors.initials: M
authors.lastname: Harzheim
mesh_terms: D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D020275:Guillain-Barre Syndrome / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008775:Methylprednisolone / Q000627:therapeutic use*
chemical_list: D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D008775:Methylprednisolone